Last reviewed · How we verify
Ruxolitinib plus simvastatin
At a glance
| Generic name | Ruxolitinib plus simvastatin |
|---|
| Sponsor | Fundación de investigación HM |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 2 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.